"10.1371_journal.pone.0143583","plos one","2015-11-23T00:00:00Z","Lukas Martin; Rebecca De Santis; Patrick Koczera; Nadine Simons; Hajo Haase; Lena Heinbockel; Klaus Brandenburg; Gernot Marx; Tobias Schuerholz","Department of Intensive Care and Intermediate Care, University Hospital RWTH, Aachen, Germany; Department of Food Chemistry and Toxicology, Berlin Institute of Technology, Berlin, Germany; Division of Biophysics, Forschungszentrum Borstel, Borstel, Germany","Conceived and designed the experiments: LM TS KB LH NS RDS. Performed the experiments: LM RDS NS LH. Analyzed the data: LM GM TS PK KB. Contributed reagents/materials/analysis tools: KB HH LH. Wrote the paper: LM TS PK HH KB GM.","KB has a patent for the structure of the synthetic antimicrobial peptide 19-2.5 (Aspidasept, Brandenburg Antiinfektiva, Borstel, Germany): Patent-No: PCT/EP2009/002565, and is chief scientific officer of Brandenburg Antiinfektiva GmbH. TS received travel grants and lecture fees from Astellas Pharma, and lecture fees from Bayer Vital, Astra-Zeneca and B. Braun Melsungen, and is chief medical officer of Brandenburg Antiinfektiva GmbH. GM has received honoraria for consulting or lecturing and restricted research grants from the following companies: BBraun, Edwards Life Sciences, Serumwerke Bernburg, Hutchinson Technology, and Baxter. The competing interests do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","11","Lukas Martin","LM",9,TRUE,6,4,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
